Psychedelics: A Beacon of Hope for Mental Health
The 2023 CNS Summit hosted a pivotal session that illuminated the evolving landscape of clinical trials and drug development...
GSK Leaders Unveil Innovative RBQM Approach: Human Aspect
In an era where clinical trials have become increasingly complex, the significance of human-centric risk management was brought to...
BMS Shows New AI-Powered Clinical Trial Patient Recruitment
During the recent SCOPE Summit Europe 2023, a remarkable session unfolded where Raul Castellanos Moreira, Rheumatology Medical Lead for...
AbbVie: Predictive Analytics Breakthrough in Site Selection
During the recent SCOPE Summit Europe 2023, a venue for experts to dissect the complexities of clinical trials, Kieran...
AstraZeneca Reveals New Clinical Trial Patient Burden Data
SCOPE Summit Europe 2023 provided a platform for industry experts to delve deep into the intricacies of modern clinical...
Discovering New ICH E6 R3 Guidance and TMF Compliance
At the Momentum Events’ ICH E6 R3 Clinical Trials Virtual Conference, which took place in early September 2023, industry...
ICH E6(R3): New Data Governance Insights for Clinical Trials
In the intricate world of clinical trials, the ICH E6(R3) guidelines stand as a beacon, guiding the path toward...
Exploring New Complexities of DCTs: Insights from Japan
DIA Japan convened a cadre of industry professionals passionate about the burgeoning realm of Decentralized Clinical Trials (DCTs). As...
ICH E6(R3) Clinical Trials: A New Era of Digital Change
Momentum Events’ ICH E6(R3) Clinical Trials Virtual Conference, which took place in early September 2023, featured esteemed clinical trial...
Decentralized Clinical Trials: Big Pharma’s New Frontier
In a recent webinar, industry luminaries including Harpreet Gill from ICON plc, Jane Twitchen from Biogen, Angela May from...